Fibrinogen, plasminogen activator inhibitor-1, and carotid intima-media wall thickness in the NHLBI Family Heart Study

Thromb Haemost. 1998 Feb;79(2):400-4.

Abstract

Several studies have linked higher plasma fibrinogen and plasminogen activator inhibitor (PAI-1) concentrations with increased risk of cardiovascular disease. We studied whether members of families with increased occurrence of coronary heart disease (CHD) have increased levels of fibrinogen and PAI-1 and whether subclinical carotid atherosclerosis is associated with these two hemostatic factors. Contrary to our hypothesis, fibrinogen and PAI-1 antigen levels were not different between high CHD risk families versus random families. Adjusted for age and family type, fibrinogen and PAI-1 were both associated positively with carotid intima-media thickness assessed by B-mode ultrasound. However, adjustment for lifestyle and medical covariates essentially eliminated these associations. These data suggest 1) elevated fibrinogen and PAI-1 do not explain clustering of CHD in families and 2) fibrinogen and PAI-1 may partly mediate the effects of other risk factors on carotid atherosclerosis, though the data are also consistent with them playing no causal role.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / pathology*
  • Carotid Arteries / pathology*
  • Female
  • Fibrinogen / metabolism*
  • Humans
  • Hyperplasia
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / blood*
  • Risk Factors
  • Tunica Intima / pathology
  • Tunica Media / pathology

Substances

  • Plasminogen Activator Inhibitor 1
  • Fibrinogen